|1.||Haberal, Mehmet: 95 articles (11/2015 - 02/2002)|
|2.||Kamar, Nassim: 85 articles (10/2015 - 04/2003)|
|3.||Rostaing, Lionel: 82 articles (10/2015 - 02/2003)|
|4.||Haberal, M: 76 articles (07/2015 - 05/2000)|
|5.||Neuhaus, Peter: 71 articles (12/2015 - 01/2002)|
|6.||Lazarus, Hillard M: 71 articles (11/2015 - 01/2002)|
|7.||Champlin, Richard E: 70 articles (12/2015 - 03/2002)|
|8.||Busuttil, Ronald W: 70 articles (11/2015 - 01/2002)|
|9.||Storb, Rainer: 66 articles (11/2015 - 01/2002)|
|10.||Maehara, Yoshihiko: 65 articles (06/2015 - 08/2002)|
06/01/2014 - "Due to the lack of well-designed clinical studies it is difficult to determine the best treatment course regarding solid organ transplant recipients presenting with invasive fungal infections. "
08/01/2014 - "Pulmonary complications after solid-organ transplantation, and particularly infections, are able to compromise the extremely good results of the transplant procedures. "
01/01/2014 - "This case and our review of the literature suggest that open extensive disinfection followed by tissue flap coverage is highly effective in controlling thoracic aortic prosthetic graft infection and may be considered as first-line treatment in such high-risk aortic arch redo patients. "
01/01/2013 - "Infected non-unions are best treated with exchange nailing, antibiotic administration and when infection has been eradicated with graft implantation if it is needed. "
12/01/2010 - "A primary goal in organ transplant is the prevention or effective treatment of infection, which is the most common life-threatening complication of long-term immunosuppressive therapy. "
09/01/2014 - "We hypothesized that any residual disease would be maximally reduced at the time of transplant, resulting in the best milieu and most lead time for developing a graft-versus-leukemia effect and in improved long-term overall survival (OS) without excess toxicity. "
12/01/2011 - "For those transplanted in first complete remission (CR1), outcomes are the best, but some fraction of those might have had extended leukemia-free survival in the absence of a transplant. "
07/01/2004 - "The CD8-HDM Cell Separation System appears to be highly selective and effective in depleting CD8+ T cells from DLI apheresis products, and CD8-depleted DLI is capable of mediating a graft-versus-leukemia effect while minimizing GVHD."
02/01/1995 - "Whereas immunomagnetic CD34+ selection is most effective in terms of elimination of T cells, the less intensive T and NK cell depletions achieved with CAMPATH-1 might be advantageous with regard to retaining engraftment potential and graft-vs.-leukemia (GVL) activity of PBPC allografts."
10/01/2002 - "It is concluded that the models established in this study are stable and direct with an excellent reproducibility and an accuracy, which can be used to evaluate purging efficacy of leukemia cells in model graft using immunomagnetic selection and the experimental studies on tumorcidal effect in vitro."
09/01/2008 - "Although the heterogeneity of different studies precludes their collection for a meta-analysis, it can be inferred that adoptive therapy with EBV-specific CTL is safe, well tolerated and particularly effective in the case of most immunogenic tumors, like post-transplant lymphoproliferative disease."
09/01/2015 - "Patient-derived xenograft (PDX) tumor models have emerged as a new approach to evaluate the effects of cancer drugs on patients' personalized tumor grafts enabling to select the best treatment for the cancer patient and providing a new tool for oncology drug developers. "
03/01/2014 - "For invasive urothelial tumor, radical cystectomy in renal transplant patients remains the best treatment. "
04/01/2012 - "Autogenic bone grafts, either vascularized or nonvascularized are the best treatment method for the large defects after tumor curettage or resection. "
01/01/2012 - "The results have dramatically improved with implementation of surveillance, careful selection of patients for transplantation, and pre-transplant tumor ablation. "
|4.||Wounds and Injuries (Trauma)
05/01/2014 - "Sensory nerve grafts, the clinical "gold standard", and most alternative techniques for bridging nerve gaps, promote reliable axon regeneration only across nerve gaps <2cm in length, and with few axons regenerating when nerve repairs are performed >2 months post-trauma or for patients >20 years of age. "
02/01/2014 - "Tissue-engineered dermis (TED) is thought to be the best treatment for skin defect wounds; however, lack of vascular structures in these products can cause slow vascularization or even transplant failure. "
12/01/2012 - "Tissue grafts and vascularised flaps (either pedicled or free) bring healthy tissue to a compromised wound for optimal healing and are the current gold standard for the repair of such defects, but disadvantages are their limited availability, the difficulty of shaping the flap to fit the defect and, most importantly, donor site morbidity. "
01/01/2006 - "However, wound complications as probably the most common type of post-transplantation surgical complication can still limit these improved outcomes and result in prolonged hospitalization, hospital readmission, and reoperation, consequently increasing overall transplant cost. "
01/01/2002 - "The best results were achieved in young patients up to the age of 20, in timely operations within 3 months, in nerve grafts up to the length of 5 cm. A simple cut wound provides much better conditions for a successful auto-transplantation of a nerve graft as compared to other more complicated injuries (e.g. "
|5.||Pathologic Constriction (Stenosis)
01/01/2016 - "Autologous venous grafts generally give best results for arterial bypass grafting in cases of arterial stenosis. "
01/01/2006 - "Thus, short-term outcomes of urethroplasty with buccal transplant showed this operation to be highly effective in correction of long recurrent strictures of anterior urethra in males."
04/01/2000 - "We find that auricular cartilage grafts are highly effective when used in a primary single-stage procedure in children with grade I or II stenosis. "
09/01/1995 - "Percutaneous techniques are most effective in treating failing but patent angioaccess grafts, especially those with stenoses remote from the venous anastomosis. "
12/01/1987 - "Best results were obtained with a discrete stenosis at a graft-to-vein anastomosis. "
|4.||Polyethylene Terephthalates (Polyethylene Terephthalate)
|6.||Anti-Bacterial Agents (Antibiotics)
|2.||Transplantation (Transplant Recipients)
|4.||Drug Therapy (Chemotherapy)
|5.||Coronary Artery Bypass (Coronary Artery Bypass Surgery)